Is Bed Bath & Beyond Viable After Q4 Earnings?

Photo of Chris Lange
By Chris Lange Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Is Bed Bath & Beyond Viable After Q4 Earnings?

© Raysonho @ Open Grid Scheduler / Grid Engine / Wikimedia Commons

Bed Bath & Beyond Inc. (NASDAQ: BBBY) reported its fiscal fourth-quarter financial results after the markets closed on Wednesday, the retailer said that it had $0.38 in earnings per share (EPS) and $3.1 billion in revenue. Consensus estimates had called for a net loss of $0.05 per share and $3.0 billion in revenue. The same period of last year reportedly had $1.20 in EPS and $3.31 billion in revenue.

During the most recent quarter, net sales decreased by 6.1% year over year and comparable sales decreased 5.6%. Overall, comparable sales from stores were 10% lower, though comparable sales from digital channels increased by 16%.

Bed Bath & Beyond ended the fiscal full year with approximately $1.4 billion in cash and investments, an increase of approximately 39%, compared with $1.0 billion in cash and investments at the end of fiscal 2018.

The company noted that it will not provide guidance for the time being, as the duration and extent of the pandemic is highly uncertain. Ultimately, Bed Bath & Beyond results are expected to be negatively affected by the COVID-19 pandemic.

Mark Tritton, Bed Bath & Beyond’s president and CEO, commented:

We are executing a clear plan to manage our business efficiently and effectively through the coronavirus pandemic, prioritizing the health and safety of our customers and teams.  Our financial position and contingency plans will allow us to retain the financial flexibility to make targeted investments that will deepen our connection with our customers and rebuild our authority in the Home space.  In this time when Home is even more central to our lives and being safe at home with family is essential, Bed Bath & Beyond takes on an even more important role supporting customers and their families by making it easy to feel at home.

[nativounit]

Bed Bath & Beyond stock traded up 15% early Thursday to $5.11, in a 52-week range of $3.43 to $17.79. The consensus price target is $8.00.

[recirclink id=682619][wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618